Traferox Technologies Inc
$300,000.00 CAD
≈ 4 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- October 1, 2024 – June 29, 2025
- Reference
- nrc-cnrc:172-2024-2025-Q3-1023909
Published purpose
Traferox will design, manufacture, and validate a system to perform normothermic ex vivo perfusion of the pancreas. In normothermic ex vivo pancreas perfusion, the excised pancreas is perfused with a solution containing red blood cells and maintained at body temperature for several hours in preparation for transplantation. Normothermic ex vivo pancreas perfusion enables detailed functional assessment of the organ and assessment of their suitability for transplant, as well as functional improvement. This project will create a system suitable for preclinical and clinical research.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions